Granulocyte colony-stimulating factor mobilizes peripheral blood CD34+ cells in patients with type 2 diabetes mellitus

Li-dong Dou,Xiao-lan Cui,Jian-he Chen,Li-mei Wang,Yi-zhong Wang
DOI: https://doi.org/10.3969/j.issn.1673-8225.2011.23.026
2011-01-01
Abstract:BACKGROUND: The number of mobilized peripheral blood CD34 + cells significantly decreases in type 2 diabetes mellitus patients compared with normal subjects. OBJECTIVE: To investigate the changes of mobilized peripheral blood CD34 + cells in type 2 diabetes mellitus patients. METHODS: A total of 234 patients with type 2 diabetes mellitus were divided into five categories according to disease duration, newly diagnosed type 2 diabetes (≤1 year) and diabetes duration (1-5, 5-10, 10-15, ≥15 years). CD34 + cells were mobilized with granulocyte colony-stimulating factor. Five days later, the number of peripheral blood CD34 + cells was detected with flow cytometry. Its relationship with disease duration, blood lipids and uric acid was analyzed by person-related analysis and multiple regression analysis. RESULTS AND CONCLUSION: The number of mobilized peripheral blood CD34 + cells was associated with the triacylglycerol (r=-0.202, P=0.002), the apoprotein-B (r=-0.276, P=0.000), and the uric acid (r=-0.297, P=0.000). Statistical analysis found that, the number of mobilized peripheral blood CD34 + cells decreased with development of diabetes mellitus.
What problem does this paper attempt to address?